tiprankstipranks
pc:lpoxy

LPOXY Therapeutics Inc

LPOXY Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing SIDIPREV™, a novel non-antibiotic therapy aimed at preventing Clostridioides difficile infections. This innovative therapy, delivered as an orally administered, enteric-coated capsule, releases oxygen into the lower gastrointestinal tract to create an environment hostile to anaerobic pathogens, addressing a critical unmet need in infection prevention for high-risk hospitalized patients.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$28M
Total Amount Raised$28M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$28M
Latest Funding Amount$28M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 03, 2025
Series A
$28.00M

Investors

Investor Name
Funding Round

Related News and Analysis